A study on the clinical profile of dermatoses induced by topical corticosteroids

Authors

  • Vontela Rohit Department of DVL, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India
  • S. Rajesh Reddy Department of DVL, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India
  • Narendar Gajula Department of DVL, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India
  • Karing Deepthi Department of DVL, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20210041

Keywords:

Topical corticosteroids, Steroid abuse, Adverse effects

Abstract

Background: Topical corticosteroids (TC), commonly used for a wide range of skin disorders, are associated with many side effects with their overuse, abuse and over-the-counter use as a cosmetic. This article aims to study clinical presentation of various dermatoses induced by abuse of TC in order to bring awareness among patients and practitioners to use topical corticosteroids with utmost caution.

Methods: This study was conducted at DVL department of a tertiary care teaching hospital over 23 consecutive months. A total of 200 consecutive patients of all ages and both genders with topical steroid induced dermatoses were included in the study. A detailed clinical evaluation was undertaken, data was then recorded and analysed.

Results: Majority of the patients were females (56%). Most common age group was 20-29 years (42%). Majority used TC as a remedy for dermatophytosis (38%), followed by use as a fairness/cosmetic cream (20%). Most of patients (29.5%) used TC for 6 months duration. Most commonly used TC formulation was 0.05% clobetasol propionate (37.5%). Majority patients (62%) did not have a valid prescription of which 47% used TC on Quacks’s advice. The most common side effects encountered were tinea incognito (33%), steroid-induced acne (20.5%), hyperpigmentation (14.5%), and hypopigmentation in 22 (11%).

Conclusions: Present study highlights irrational prescription of TC by non-dermatologists for dermatophytosis which are very common in this particular study region and emphasizes the need to educate patients about serious adverse effects of TC abuse.

Metrics

Metrics Loading ...

Author Biographies

Vontela Rohit, Department of DVL, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India

Assistant Professor, Department of DVL

Narendar Gajula, Department of DVL, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India

Professor,Department of DVL

Karing Deepthi, Department of DVL, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India

Post Graduate,Department of DVL

References

Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19:101-2.

United States’ classification system. Glucocorticoids Fitzpatrick’s Dermatology. Chapter 184. Ninth edition.

Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1-15.

Yohn JJ, Weston WL. Topical glucocorticosteroids. Curr Probl Dermatol. 1990;2:38-63.

Wolverton SE. Topical Corticosteroids. Comprehensive Dermatologic Drug Therapy. 2nd ed. Philadelphia USA: Saunders Elsevier. 2007;595-624.

Saraswat A, Lahiri K, Chatterjee M, Barua S, Coondoo A, Mittal A, et al. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Indian J Dermatol Venereol Leprol. 2011;77:160-6.

Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol Online J. 2014;5:416-25.

Dey VK. Misuse of topical corticosteroids: A clinical study of adverse effects. Indian Dermatol Online J. 2014;5(4):436-40.

Hameed AF. Steroid dermatitis resembling rosacea: A clinical evaluation of 75 patients. ISRN Dermatol. 2013;491376.

Abrahm A, Roga G. Topical steroid- damaged skin. Indian J Dermatol. 2014;59:456-9.

Majid I. Mometasone-based triple combination therapy in melasma: is it really safe? Indian J Dermatol. 2010;55:359-62.

Saraswat A. Topical corticosteroid use in children: Adverse effects and how to minimize them. Indian J Dermatol Venereol Leprol. 2010;76:225-8.

Kumar MA, Noushad PP, Shailaja K, Jayasutha J, Ramasamy C. A study on drug prescribing pattern and use of corticosteroids in dermatological conditions at a tertiary care teaching hospital. Int J Pharm Sci Rev Res. 2011;9:132-5.

Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142:931-6.

Rathi SK, Kumrah L. Topical corticosteroid-induced rosacea-like dermatitis: A clinical study of 110 cases. Indian J Dermatol Venereol Leprol. 2011;77:42-6.

Saraswat A. Contact allergy to topical corticosteroids and sunscreens. Indian J Dermatol Venereol Leprol. 2012;78:552-9.

Rathod SS, Motghare VM, Deshmukh VS, Deshpande RP, Bhamare CG, Patil JR. Prescribing practices of topical corticosteroids in the outpatient dermatology department of a rural tertiary care teaching hospital. Indian J Dermatol. 2013;58:342-5.

Coondoo A, Chattopadhyay C. Use and abuse of topical corticosteroids in children. Indian J Paediatr Dermatol. 2014;15:1-4.

Mehta AB, Nadkarni NJ, Patil SP, Godse KV, Gautam M, Agarwal S. Topical corticosteroids in dermatology. Indian J Dermatol Venereol Leprol. 2016;82:371.

Downloads

Published

2021-02-22

How to Cite

Rohit, V., Reddy, S. R., Gajula, N., & Deepthi, K. (2021). A study on the clinical profile of dermatoses induced by topical corticosteroids. International Journal of Research in Dermatology, 7(2), 177–183. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20210041

Issue

Section

Original Research Articles